Aqsens Health has developed a novel fuzzy assay platform that can point out diseases and conditions early on. In a new publication in Bioanalytical Chemistry by Kulpakko et al, this Aqsens Health’s unique assay platform has been utilized in detection of urinary tract infection and it’s causes. The unique combination of the proprietary and
Aqsens Health Private Limited and Public Health Foundation of India signed a partnership for screening of oral cancer and anaemia.
Finnish startup Aqsens Health and the Public Health Foundation of India signed an agreement (September, 2018) to collaborate in the area of non-invasive saliva based health screening solutions based on Aqsens’ technology. The collaborative project agreement complements an earlier MoU with wider scope that the Parties signed in May, 2018. Both Aqsens and PHFI are
I remember the moment landing to Bangalore for the first time 2,5 years ago with the purpose to activate collaboration with our research partners and search for new ones around our oral cancer screening project and start finalising the development work so that we could bring our solution to the market. Arriving to India
On April 10th 2017 the Department of Biotechnology of India, Centre for Cellular and Molecular Platforms (C-CAMP) and Aqsens Health Pvt Ltd have with the support of Team Finland and collaborating local partners launch a long-term collaboration project to validate and bring to the market saliva based oral cancer screening method developed by Finnish
Aqsens Health Pvt Ldt and Biocon Foundation signed an agreement on preventive Oral Cancer Screening project
Finnish startup Aqsens Health and Biocon Foundation have signed an agreement to collect early stage oral cancer samples for testing and validating Aqsens’ E-TRF method in detecting early stage Oral Cancer indicators from oral rinse. The aim of the project is to validate and optimise the commercial solution for remote monitoring starting from India.